Cellular and tissue context is paramount; the downstream consequences of miR-21 targeting specific genes (like PTEN or PDCD4) may differ significantly depending on the specific GI cell type, the cancer stage, and the surrounding tumor microenvironment (TME). This evidence concerns the gene PDCD4 and cancer.